{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:39:58Z","timestamp":1785451198489,"version":"3.56.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15-HL-154068-01"],"award-info":[{"award-number":["1R15-HL-154068-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Throughout a person\u2019s lifetime, thyroid hormones (THs) have an outsized impact on cardiovascular health from prenatal heart development to adult cardiac contractile function and blood pressure regulation. Maintaining a healthy functioning hypothalamic-thyroid axis is crucial for preventing cardiac-related and all-cause mortality. Patients with moderate to severe heart failure (HF) often manifest with low or borderline-low TH function. In this review article, we examine the potential of TH therapy in HF management by highlighting outcomes from recent clinical studies. We also address the need for a serum-based biomarker such as brain natriuretic peptide (BNP) that indicates disease stage of HF and that also correlates with cardiac tissue TH status. Recent and newer therapeutic strategies (including the combination of Triiodothyronine and Thyroxine) to advance the management of patients living with HF are proposed including a reassessment of what is normal thyroid status in these patients and the potential of TH treatment.<\/jats:p>","DOI":"10.1186\/s10020-025-01351-x","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:36:34Z","timestamp":1764660994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rethinking strategies for solving thyroid dysfunction at the heart of cardiovascular disease"],"prefix":"10.1186","volume":"32","author":[{"given":"Viswanathan","family":"Rajagopalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaie","family":"Ojamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Martin","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"1351_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.yjmcc.2015.10.019","volume":"89","author":"H Alonso","year":"2015","unstructured":"Alonso H, Fernandez-Ruocco J, Gallego M, et al. Thyroid stimulating hormone directly modulates cardiac electrical activity. J Mol Cell Cardiol. 2015;89:280\u20136.","journal-title":"J Mol Cell Cardiol"},{"key":"1351_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ehf2.12025","volume":"2","author":"A Amin","year":"2015","unstructured":"Amin A, Chitsazan M, Taghavi S, Ardeshiri M. Effects of Triiodothyronine replacement therapy in patients with chronic stable heart failure and low-triiodothyronine syndrome: a randomized, double-blind, placebo-controlled study. ESC Heart Fail. 2015;2:5\u201311.","journal-title":"ESC Heart Fail"},{"key":"1351_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10020-019-0120-3","volume":"25","author":"S An","year":"2019","unstructured":"An S, Gilani N, Huang Y, et al. Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose Triiodothyronine treatment. Mol Med. 2019;25:53.","journal-title":"Mol Med"},{"key":"1351_CR4","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.cpcardiol.2023.101719","volume":"48","author":"SP Ang","year":"2023","unstructured":"Ang SP, Chia JE, Jaiswal V, et al. Subclinical hypothyroidism and clinical outcomes after percutaneous coronary intervention: A Meta-Analysis. Curr Probl Cardiol. 2023;48:101719.","journal-title":"Curr Probl Cardiol"},{"key":"1351_CR5","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1210\/jc.2004-2111","volume":"90","author":"BC Appelhof","year":"2005","unstructured":"Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with Levothyroxine and liothyronine in two ratios, compared with Levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. 2005;90:2666\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1067\/mhj.2001.119370","volume":"142","author":"J Auer","year":"2001","unstructured":"Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J. 2001;142:838\u201342.","journal-title":"Am Heart J"},{"key":"1351_CR7","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","volume":"136","author":"C Baumgartner","year":"2017","unstructured":"Baumgartner C, da Costa BR, Collet TH, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136:2100\u201316.","journal-title":"Circulation"},{"key":"1351_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11154-022-09713-0","volume":"23","author":"A Bekiaridou","year":"2022","unstructured":"Bekiaridou A, Kartas A, Moysidis DV, et al. The bidirectional relationship of thyroid disease and atrial fibrillation: established knowledge and future considerations. Rev Endocr Metab Disord. 2022;23:621\u201330.","journal-title":"Rev Endocr Metab Disord"},{"key":"1351_CR9","doi-asserted-by":"publisher","first-page":"e230027","DOI":"10.20945\/2359-4292-2023-0027","volume":"68","author":"F Bioletto","year":"2024","unstructured":"Bioletto F, Cuboni D, Varaldo E, et al. Severe hypothyroidism as a trigger for Brugada-type ECG abnormalities: a case report and literature review. Arch Endocrinol Metab. 2024;68:e230027.","journal-title":"Arch Endocrinol Metab"},{"key":"1351_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1089\/thy.2023.0135","volume":"33","author":"B Biondi","year":"2023","unstructured":"Biondi B, Pucci M, Pontieri G, Formisano P, Esposito R. Preliminary results of a Double-Blind randomized controlled trial evaluating the cardiometabolic effects of Levothyroxine and liothyronine compared to Levothyroxine with placebo in athyreotic Low-Risk thyroid cancer patients. Thyroid. 2023;33:1402\u201313.","journal-title":"Thyroid"},{"key":"1351_CR11","volume-title":"Werner & Ingbar's The Thyroid","author":"LE Braverman","year":"2020","unstructured":"Braverman LE. Werner & Ingbar\u2019s The Thyroid. 11th ed. Wolters Kluwer Health; 2020.","edition":"11"},{"key":"1351_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1590\/S0004-27302013000400003","volume":"57","author":"G Brenta","year":"2013","unstructured":"Brenta G, Vaisman M, Sgarbi JA, et al. Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metabol. 2013;57:265\u201391.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1351_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/ejendo\/lvad172","volume":"190","author":"G Brigante","year":"2024","unstructured":"Brigante G, Santi D, Boselli G, et al. Randomized double-blind placebo-controlled trial on Levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study. Eur J Endocrinol. 2024;190:12\u201322.","journal-title":"Eur J Endocrinol"},{"key":"1351_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12020-023-03363-1","volume":"81","author":"I Buber","year":"2023","unstructured":"Buber I, Eraydin A, Sevgican CI, Tekin I, Kilic ID, Fenkci SM. The effects of combination treatment with LT4 and LT3 on diastolic functions and atrial conduction time in LT4-treated women with low T3: a short term follow-up study. Endocrine. 2023;81:316\u201321.","journal-title":"Endocrine"},{"key":"1351_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJM199902113400603","volume":"340","author":"R Bunevicius","year":"1999","unstructured":"Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Jr. Effects of thyroxine as compared with thyroxine plus Triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340:424\u20139.","journal-title":"N Engl J Med"},{"key":"1351_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13105-023-01000-z","volume":"80","author":"O Casis","year":"2024","unstructured":"Casis O, Echeazarra L, Saenz-Diez B, Gallego M. Deciphering the roles of Triiodothyronine (T3) and thyroid-stimulating hormone (TSH) on cardiac electrical remodeling in clinical and experimental hypothyroidism. J Physiol Biochem. 2024;80:1\u20139.","journal-title":"J Physiol Biochem"},{"key":"1351_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-022-00357-7","volume":"8","author":"L Chaker","year":"2022","unstructured":"Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022;8:30.","journal-title":"Nat Rev Dis Primers"},{"key":"1351_CR18","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Sloan O, Dickerson B, Chakraborty G, Li S, Bounds C, Lemus S, Hickman C, Calabrese JM, Rajagopalan V.\u00a0Noncoding and coding mechanisms of aging-related heart failure with preserved ejection fraction associated with thyroid dysfunction. Dis Model Mech. 2025;18(11):dmm052207.","DOI":"10.1242\/dmm.052207"},{"key":"1351_CR19","doi-asserted-by":"publisher","first-page":"H1309","DOI":"10.1152\/ajpheart.00272.2024","volume":"327","author":"A Charest","year":"2024","unstructured":"Charest A, Nasta N, Siddiqui S, et al. Nanoscale organization of cardiac calcium channels is dependent on thyroid hormone status. Am J Physiol Heart Circ Physiol. 2024;327:H1309\u201326.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1351_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/MAJ.0000000000000524","volume":"350","author":"P Chen","year":"2015","unstructured":"Chen P, Li S, Lei X, et al. Free Triiodothyronine levels and short-term prognosis in chronic heart failure patients with type 2 diabetes. Am J Med Sci. 2015;350:87\u201394.","journal-title":"Am J Med Sci"},{"key":"1351_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ejhf.42","volume":"16","author":"S Chen","year":"2014","unstructured":"Chen S, Shauer A, Zwas DR, Lotan C, Keren A, Gotsman I. The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail. 2014;16:217\u201326.","journal-title":"Eur J Heart Fail"},{"key":"1351_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1067\/mtc.2001.116192","volume":"122","author":"D Chowdhury","year":"2001","unstructured":"Chowdhury D, Ojamaa K, Parnell VA, McMahon C, Sison CP, Klein I. A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg. 2001;122:1023\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1351_CR23","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","volume":"78","author":"MG Del Buono","year":"2021","unstructured":"Del Buono MG, Montone RA, Camilli M, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-Art review. J Am Coll Cardiol. 2021;78:1352\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"1351_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526\u201334.","journal-title":"Arch Intern Med"},{"key":"1351_CR25","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1161\/CIRCULATIONAHA.118.036859","volume":"139","author":"AR Cappola","year":"2019","unstructured":"Cappola AR, Desai AS, Medici M, et al. Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment. Circulation. 2019;139:2892\u2013909.","journal-title":"Circulation"},{"key":"1351_CR26","doi-asserted-by":"crossref","unstructured":"de Lima Beltrao FE, Carvalhal G, de Almeida Beltrao DC et al. Treatment preferences in patients with hypothyroidism: an analysis of eleven randomized controlled trials. J Clin Endocrinol Metab. 2025;110(3):887\u2013900.","DOI":"10.1210\/clinem\/dgae651"},{"key":"1351_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","volume":"104","author":"GP Diniz","year":"2009","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3beta\/mTOR signaling pathway. Basic Res Cardiol. 2009;104:653\u201367.","journal-title":"Basic Res Cardiol"},{"key":"1351_CR28","volume-title":"Thyroid Hormone Receptors in Control of Heart Rate","author":"R Dore","year":"2024","unstructured":"Dore R, Mittag J. Thyroid Hormone Receptors in Control of Heart Rate, vol. 165. Endocrinology; 2024."},{"key":"1351_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.hrtlng.2020.08.023","volume":"49","author":"R Doshi","year":"2020","unstructured":"Doshi R, Dhawan T, Rendon C, et al. New-onset arrhythmia associated with patients hospitalized for thyroid dysfunction. Heart Lung. 2020;49:758\u201362.","journal-title":"Heart Lung"},{"key":"1351_CR30","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.12998\/wjcc.v10.i11.3624","volume":"10","author":"F Du","year":"2022","unstructured":"Du F, Liu SW, Yang H, Duan RX, Ren WX. Thyrotoxicosis after a massive Levothyroxine ingestion: A case report. World J Clin Cases. 2022;10:3624\u20139.","journal-title":"World J Clin Cases"},{"key":"1351_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1089\/thy.2021.0304","volume":"32","author":"AM Dumitrescu","year":"2022","unstructured":"Dumitrescu AM, Hanlon EC, Arosemena M, et al. Extended absorption of liothyronine from Poly-Zinc-Liothyronine: results from a phase 1, Double-Blind, randomized, and controlled study in humans. Thyroid. 2022;32:196\u2013205.","journal-title":"Thyroid"},{"key":"1351_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7326\/0003-4819-142-6-200503150-00007","volume":"142","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142:412\u201324.","journal-title":"Ann Intern Med"},{"key":"1351_CR33","doi-asserted-by":"publisher","first-page":"e2211863","DOI":"10.1001\/jamanetworkopen.2022.11863","volume":"5","author":"JM Evron","year":"2022","unstructured":"Evron JM, Hummel SL, Reyes-Gastelum D, Haymart MR, Banerjee M, Papaleontiou M. Association of thyroid hormone treatment intensity with cardiovascular mortality among US veterans. JAMA Netw Open. 2022;5:e2211863.","journal-title":"JAMA Netw Open"},{"key":"1351_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.14310\/horm.2002.1274","volume":"9","author":"VV Fadeyev","year":"2010","unstructured":"Fadeyev VV, Morgunova TB, Melnichenko GA, Dedov II. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism. Horm (Athens). 2010;9:245\u201352.","journal-title":"Horm (Athens)"},{"key":"1351_CR35","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s40618-023-02229-7","volume":"47","author":"U Feldt-Rasmussen","year":"2024","unstructured":"Feldt-Rasmussen U, Effraimidis G, Bliddal S, Klose M. Risks of suboptimal and excessive thyroid hormone replacement across ages. J Endocrinol Invest. 2024;47:1083\u201390.","journal-title":"J Endocrinol Invest"},{"key":"1351_CR36","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41467-020-16345-y","volume":"11","author":"A Ferdous","year":"2020","unstructured":"Ferdous A, Wang ZV, Luo Y, et al. FoxO1-Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth. Nat Commun. 2020;11:2551.","journal-title":"Nat Commun"},{"key":"1351_CR37","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1089\/thy.2018.0709","volume":"29","author":"J Fernandez-Ruocco","year":"2019","unstructured":"Fernandez-Ruocco J, Gallego M, Rodriguez-de-Yurre A, et al. High Thyrotropin is critical for cardiac electrical remodeling and arrhythmia vulnerability in hypothyroidism. Thyroid. 2019;29:934\u201345.","journal-title":"Thyroid"},{"key":"1351_CR38","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American association of clinical endocrinologists and the American thyroid association. Endocr Pract. 2012;18:988\u20131028.","journal-title":"Endocr Pract"},{"key":"1351_CR39","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1089\/thy.2012.0205","volume":"22","author":"JR Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American association of clinical endocrinologists and the American thyroid association. Thyroid. 2012;22:1200\u201335.","journal-title":"Thyroid"},{"key":"1351_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.109.917922","volume":"122","author":"AM Gerdes","year":"2010","unstructured":"Gerdes AM, Iervasi G. Thyroid replacement therapy and heart failure. Circulation. 2010;122:385\u201393.","journal-title":"Circulation"},{"key":"1351_CR41","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/j.2040-4603.2016.tb00704.x","volume":"6","author":"AM Gerdes","year":"2016","unstructured":"Gerdes AM, Ojamaa K. Thyroid hormone and cardioprotection. Compr Physiol. 2016;6:1199\u2013219.","journal-title":"Compr Physiol"},{"key":"1351_CR42","doi-asserted-by":"publisher","first-page":"H1005","DOI":"10.1152\/ajpheart.00748.2024","volume":"328","author":"AM Gerdes","year":"2025","unstructured":"Gerdes AM. Cardiac remodeling in heart disease and the importance of thyroid hormones. Am J Physiol Heart Circ Physiol. 2025;328:H1005\u201318.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"1351_CR43","first-page":"ajpheart00704","volume":"2014","author":"AM Gerdes","year":"2014","unstructured":"Gerdes AM. Restoration of thyroid hormone balance: A game changer in the treatment of heart failure? Am J Physiol Heart Circ Physiol. 2014;2014:ajpheart00704.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1351_CR44","doi-asserted-by":"publisher","first-page":"H1919","DOI":"10.1152\/ajpheart.00105.2021","volume":"320","author":"AM Gerdes","year":"2021","unstructured":"Gerdes AM, Portman MA, Iervasi G, Pingitore A, Cooper DKC, Novitzky D. Ignoring a basic pathophysiological mechanism of heart failure progression will not make it go away. Am J Physiol Heart Circ Physiol. 2021;320:H1919\u201322.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1351_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2017.05.042","volume":"243","author":"C Gil-Cayuela","year":"2017","unstructured":"Gil-Cayuela C, Rosello LE, Tarazon E, et al. Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: an epigenomic study. Int J Cardiol. 2017;243:27\u201333.","journal-title":"Int J Cardiol"},{"key":"1351_CR46","doi-asserted-by":"publisher","first-page":"e0190987","DOI":"10.1371\/journal.pone.0190987","volume":"13","author":"C Gil-Cayuela","year":"2018","unstructured":"Gil-Cayuela C, Ortega A, Tarazon E, et al. Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis. PLoS ONE. 2018;13:e0190987.","journal-title":"PLoS ONE"},{"key":"1351_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.06.010","volume":"160","author":"N Gilani","year":"2021","unstructured":"Gilani N, Wang K, Muncan A, et al. Triiodothyronine maintains cardiac transverse-tubule structure and function. J Mol Cell Cardiol. 2021;160:1\u201314.","journal-title":"J Mol Cell Cardiol"},{"key":"1351_CR48","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0002-9149(97)00950-8","volume":"81","author":"MA Hamilton","year":"1998","unstructured":"Hamilton MA, Stevenson LW, Fonarow GC, et al. Safety and hemodynamic effects of intravenous Triiodothyronine in advanced congestive heart failure. Am J Cardiol. 1998;81:443\u20137.","journal-title":"Am J Cardiol"},{"key":"1351_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ehf2.12084","volume":"3","author":"T Hayashi","year":"2016","unstructured":"Hayashi T, Hasegawa T, Kanzaki H, et al. Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure. ESC Heart Fail. 2016;3:168\u201376.","journal-title":"ESC Heart Fail"},{"key":"1351_CR50","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1373\/clinchem.2018.293480","volume":"64","author":"JL Hejl","year":"2018","unstructured":"Hejl JL, Grand MK, Siersma V, et al. Brain natriuretic peptide in plasma as predictor of All-Cause mortality in a large Danish primary health care population suspected of heart failure. Clin Chem. 2018;64:1723\u201331.","journal-title":"Clin Chem"},{"key":"1351_CR51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fendo.2019.00544","volume":"10","author":"T Idrees","year":"2019","unstructured":"Idrees T, Price JD, Piccariello T, Bianco AC. Sustained release T3 therapy: animal models and translational applications. Front Endocrinol (Lausanne). 2019;10:544.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1351_CR52","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.CIR.0000048124.64204.3F","volume":"107","author":"G Iervasi","year":"2003","unstructured":"Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107:708\u201313.","journal-title":"Circulation"},{"key":"1351_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2017","unstructured":"Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14:39\u201355.","journal-title":"Nat Rev Cardiol"},{"key":"1351_CR54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.actbio.2018.08.003","volume":"78","author":"C Jackman","year":"2018","unstructured":"Jackman C, Li H, Bursac N. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function. Acta Biomater. 2018;78:98\u2013110.","journal-title":"Acta Biomater"},{"key":"1351_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000469708","volume":"6","author":"R Janssen","year":"2017","unstructured":"Janssen R, Muller A, Simonides WS. Cardiac thyroid hormone metabolism and heart failure. Eur Thyroid J. 2017;6:130\u20137.","journal-title":"Eur Thyroid J"},{"key":"1351_CR56","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1210\/en.2012-2017","volume":"154","author":"R Janssen","year":"2013","unstructured":"Janssen R, Zuidwijk M, Muller A, Mulders J, Oudejans CB, Simonides WS. Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency MicroRNA signature from the Dlk1-Dio3 genomic region. Endocrinology. 2013;154:1973\u20138.","journal-title":"Endocrinology"},{"key":"1351_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fendo.2016.00022","volume":"7","author":"R Janssen","year":"2016","unstructured":"Janssen R, Zuidwijk MJ, Muller A, et al. MicroRNA 214 is a potential regulator of thyroid hormone levels in the mouse heart following myocardial infarction, by targeting the thyroid-Hormone-Inactivating enzyme deiodinase type III. Front Endocrinol (Lausanne). 2016;7:22.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1351_CR58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/jamacardio.2022.5309","volume":"8","author":"X Jia","year":"2023","unstructured":"Jia X, Al Rifai M, Hoogeveen R, et al. Association of Long-term change in N-Terminal Pro-B-Type natriuretic peptide with incident heart failure and death. JAMA Cardiol. 2023;8:222\u201330.","journal-title":"JAMA Cardiol"},{"key":"1351_CR59","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24:1670\u2013751.","journal-title":"Thyroid"},{"key":"1351_CR60","doi-asserted-by":"publisher","first-page":"e005266","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","volume":"11","author":"L Kannan","year":"2018","unstructured":"Kannan L, Shaw PA, Morley MP, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Heart Fail. 2018;11:e005266.","journal-title":"Circ Heart Fail"},{"key":"1351_CR61","doi-asserted-by":"publisher","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey A, Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem. 2006;281:20666\u201372.","journal-title":"J Biol Chem"},{"key":"1351_CR62","doi-asserted-by":"publisher","first-page":"H2409","DOI":"10.1152\/ajpheart.00483.2005","volume":"289","author":"WI Khalife","year":"2005","unstructured":"Khalife WI, Tang YD, Kuzman JA, et al. Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2005;289:H2409\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1351_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/11598070-000000000-00000","volume":"72","author":"D Khandelwal","year":"2012","unstructured":"Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72:17\u201333.","journal-title":"Drugs"},{"key":"1351_CR64","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1177\/0300060516675504","volume":"45","author":"A Kibel","year":"2017","unstructured":"Kibel A, Selthofer-Relatic K, Drenjancevic I, et al. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res. 2017;45:1901\u201329.","journal-title":"J Int Med Res"},{"key":"1351_CR65","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1507\/endocrj.K07E-024","volume":"55","author":"A Kitahara","year":"2008","unstructured":"Kitahara A, Hirai R, Matsui Y, Ikeda Y, Nakamura H. A case of hypothyroidism with Brugada electrocardiographic waveforms. Endocr J. 2008;55:589\u201394.","journal-title":"Endocr J"},{"key":"1351_CR66","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501\u20139.","journal-title":"N Engl J Med"},{"key":"1351_CR67","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJM199512073332302","volume":"333","author":"JD Klemperer","year":"1995","unstructured":"Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 1995;333:1522\u20137.","journal-title":"N Engl J Med"},{"key":"1351_CR68","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0003-4975(96)00102-6","volume":"61","author":"JD Klemperer","year":"1996","unstructured":"Klemperer JD, Klein IL, Ojamaa K, et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg. 1996;61:1323\u20137. discussion 1328-9.","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"1351_CR69","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1210\/clinem\/dgaa672","volume":"105","author":"A Kotwal","year":"2020","unstructured":"Kotwal A, Cortes T, Genere N, et al. Treatment of thyroid dysfunction and serum lipids: A systematic review and Meta-analysis. J Clin Endocrinol Metab. 2020;105(12):3683\u201394.","journal-title":"J Clin Endocrinol Metab."},{"key":"1351_CR70","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cen.13472","volume":"88","author":"VL Langen","year":"2018","unstructured":"Langen VL, Niiranen TJ, Puukka P, et al. Thyroid-stimulating hormone and risk of sudden cardiac death, total mortality and cardiovascular morbidity. Clin Endocrinol (Oxf). 2018;88:105\u201313.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1351_CR71","doi-asserted-by":"crossref","unstructured":"Kostopoulos G, Effraimidis G. Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation. Eur Thyroid J. 2024;13:e230254.","DOI":"10.1530\/ETJ-23-0254"},{"key":"1351_CR72","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1210\/me.2010-0032","volume":"24","author":"YK Lee","year":"2010","unstructured":"Lee YK, Ng KM, Chan YC, et al. Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol. 2010;24:1728\u201336.","journal-title":"Mol Endocrinol"},{"key":"1351_CR73","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/cen.13052","volume":"85","author":"GP Leese","year":"2016","unstructured":"Leese GP, Soto-Pedre E, Donnelly LA. Liothyronine use in a 17 year observational population-based study - the tears study. Clin Endocrinol (Oxf). 2016;85:918\u201325.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1351_CR74","doi-asserted-by":"crossref","unstructured":"Li B, Huang Y, Li Z. Estimation of left ventricular functions in patients with subclinical hypothyroidism: a meta-analysis. Front Endocrinol. 2023;14:1279570.","DOI":"10.3389\/fendo.2023.1279570"},{"key":"1351_CR75","doi-asserted-by":"publisher","first-page":"H2137","DOI":"10.1152\/ajpheart.01379.2007","volume":"294","author":"Y Liu","year":"2008","unstructured":"Liu Y, Redetzke RA, Said S, Pottala JV, de Escobar GM, Gerdes AM. Serum thyroid hormone levels May not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism. Am J Physiol Heart Circ Physiol. 2008;294:H2137\u201343.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1351_CR76","doi-asserted-by":"publisher","first-page":"E607","DOI":"10.1210\/jc.2014-2942","volume":"100","author":"A Madathil","year":"2015","unstructured":"Madathil A, Hollingsworth KG, Blamire AM, et al. Levothyroxine improves abnormal cardiac bioenergetics in subclinical hypothyroidism: a cardiac magnetic resonance spectroscopic study. J Clin Endocrinol Metab. 2015;100:E607\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR77","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11892-020-01344-6","volume":"20","author":"P Mantzouratou","year":"2020","unstructured":"Mantzouratou P, Lavecchia AM, Novelli R, Xinaris C. Thyroid hormone signalling alteration in diabetic nephropathy and cardiomyopathy: a switch to the foetal gene programme. Curr Diab Rep. 2020;20:58.","journal-title":"Curr Diab Rep"},{"key":"1351_CR78","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.vph.2009.10.008","volume":"52","author":"J Marin-Garcia","year":"2010","unstructured":"Marin-Garcia J. Thyroid hormone and myocardial mitochondrial biogenesis. Vascul Pharmacol. 2010;52:120\u201330.","journal-title":"Vascul Pharmacol"},{"key":"1351_CR79","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1210\/jcem.86.3.7291","volume":"86","author":"F Monzani","year":"2001","unstructured":"Monzani F, Di Bello V, Caraccio N, et al. Effect of Levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab. 2001;86:1110\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR80","doi-asserted-by":"publisher","first-page":"96","DOI":"10.59556\/japi.72.0602","volume":"72","author":"H Nanjappa","year":"2024","unstructured":"Nanjappa H, Rodrigues AJ. Atrial fibrillation secondary to Levothyroxine overdose with underlying secondary infection. J Assoc Physicians India. 2024;72:96\u20138.","journal-title":"J Assoc Physicians India"},{"key":"1351_CR81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-017-0777-9","volume":"15","author":"Y Ning","year":"2017","unstructured":"Ning Y, Cheng YJ, Liu LJ, et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. BMC Med. 2017;15:21.","journal-title":"BMC Med"},{"key":"1351_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jjcc.2021.05.003","volume":"78","author":"T Nishikimi","year":"2021","unstructured":"Nishikimi T, Nakagawa Y. Potential pitfalls when interpreting plasma BNP levels in heart failure practice. J Cardiol. 2021;78:269\u201374.","journal-title":"J Cardiol"},{"key":"1351_CR83","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/1010-7940(89)90092-4","volume":"3","author":"D Novitzky","year":"1989","unstructured":"Novitzky D, Cooper DK, Swanepoel A. Inotropic effect of Triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg. 1989;3:140\u20135.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1351_CR84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-030-36871-5_3","volume-title":"Thyroid and heart: A comprehensive translational essay","author":"K Ojamaa","year":"2020","unstructured":"Ojamaa K, Carrillo-Sepulveda MA. Thyroid hormone signaling mechanisms in the heart and vasculature. In: Iervasi G, Pingitore A, Gerdes AM, Razvi S, editors. Thyroid and heart: A comprehensive translational essay. Cham: Springer International Publishing; 2020. pp. 23\u201341."},{"key":"1351_CR85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.vph.2009.11.008","volume":"52","author":"K Ojamaa","year":"2010","unstructured":"Ojamaa K. Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy. Vascul Pharmacol. 2010;52:113\u20139.","journal-title":"Vascul Pharmacol"},{"key":"1351_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-006-9323-3","volume":"297","author":"C Pantos","year":"2007","unstructured":"Pantos C, Xinaris C, Mourouzis I, Malliopoulou V, Kardami E, Cokkinos DV. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling? Mol Cell Biochem. 2007;297:65\u201372.","journal-title":"Mol Cell Biochem"},{"key":"1351_CR87","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1089\/thy.2016.0514","volume":"27","author":"BS Paolino","year":"2017","unstructured":"Paolino BS, Pomerantzeff PM, Dallan LAO, et al. Myocardial inactivation of thyroid hormones in patients with aortic stenosis. Thyroid. 2017;27:738\u201345.","journal-title":"Thyroid"},{"key":"1351_CR88","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.117.311920","volume":"121","author":"SS Parikh","year":"2017","unstructured":"Parikh SS, Blackwell DJ, Gomez-Hurtado N, et al. Thyroid and glucocorticoid hormones promote functional T-Tubule development in Human-Induced pluripotent stem Cell-Derived cardiomyocytes. Circ Res. 2017;121:1323\u201330.","journal-title":"Circ Res"},{"key":"1351_CR89","doi-asserted-by":"crossref","unstructured":"Penna GC, Bianco AC, Ettleson MD. A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone. J Clin Endocrinol Metab. 2024;109(3):e1143\u201350.","DOI":"10.1210\/clinem\/dgad629"},{"key":"1351_CR90","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/endocrines4040053","volume":"4","author":"A Pingitore","year":"2023","unstructured":"Pingitore A, Mastorci F, Lazzeri MFL, Vassalle C. Thyroid and Heart: A Fatal Pathophysiological Attraction in a Controversial Clinical Liaison. Endocrines. 2023;4:722\u201341.","journal-title":"Endocrines"},{"key":"1351_CR91","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cardfail.2006.05.009","volume":"12","author":"A Pingitore","year":"2006","unstructured":"Pingitore A, Iervasi G, Barison A, et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J Card Fail. 2006;12:520\u20136.","journal-title":"J Card Fail"},{"key":"1351_CR92","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1210\/jc.2007-2210","volume":"93","author":"A Pingitore","year":"2008","unstructured":"Pingitore A, Galli E, Barison A, et al. Acute effects of Triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008;93:1351\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR93","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.amjcard.2018.12.020","volume":"123","author":"A Pingitore","year":"2019","unstructured":"Pingitore A, Mastorci F, Piaggi P, et al. Usefulness of Triiodothyronine replacement therapy in patients with ST elevation myocardial infarction and borderline\/reduced Triiodothyronine levels (from the THIRST Study). Am J Cardiol. 2019;123:905\u201312.","journal-title":"Am J Cardiol"},{"key":"1351_CR94","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/en.2010-0431","volume":"152","author":"CJ Pol","year":"2011","unstructured":"Pol CJ, Muller A, Zuidwijk MJ, et al. Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology. 2011;152:669\u201379.","journal-title":"Endocrinology"},{"key":"1351_CR95","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.semtcvs.2022.01.005","volume":"35","author":"MA Portman","year":"2023","unstructured":"Portman MA, Slee AE, Roth SJ, et al. Triiodothyronine supplementation in infants undergoing cardiopulmonary bypass: A randomized controlled trial. Semin Thorac Cardiovasc Surg. 2023;35:105\u201312.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"1351_CR96","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0036-1583280","volume":"5","author":"M Radman","year":"2016","unstructured":"Radman M, Portman MA. Thyroid hormone in the pediatric intensive care unit. J Pediatr Intensive Care. 2016;5:154\u201361.","journal-title":"J Pediatr Intensive Care"},{"issue":"7","key":"1351_CR97","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.3390\/ijms24076560","volume":"24","author":"V Rajagopalan","year":"2023","unstructured":"Rajagopalan V, Chakraborty S, Lin R. Novel transcriptomic interactomes of noncoding RNAs in the heart under altered thyroid hormonal States. Int J Mol Sci. 2023;24(7):6560.","journal-title":"Int J Mol Sci."},{"key":"1351_CR98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-030-36871-5_11","volume-title":"Editor thyroid and heart: A comprehensive translational essay","author":"V Rajagopalan","year":"2020","unstructured":"Rajagopalan V, Gerdes AM. Physiological and pathological cardiac remodeling in altered thyroid hormone States. In: Iervasi G, et al. editors. Editor thyroid and heart: A comprehensive translational essay. 2 ed. Cham, Switzerland: Springer International Publishing; 2020. pp. 137\u201352.","edition":"2"},{"key":"1351_CR99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11897-014-0246-0","volume":"12","author":"V Rajagopalan","year":"2015","unstructured":"Rajagopalan V, Gerdes AM. Role of thyroid hormones in ventricular remodeling. Curr Heart Fail Rep. 2015;12:141\u20139.","journal-title":"Curr Heart Fail Rep"},{"key":"1351_CR100","doi-asserted-by":"crossref","unstructured":"Razvi S, Leng O, Jabbar A et al. Sample timing, diagnosis of subclinical thyroid dysfunction and mortality in acute myocardial infarction: ThyrAMI1 study. J Clin Endocrinol Metab. 2020;105(4):e1299\u20131306.","DOI":"10.1210\/clinem\/dgz143"},{"key":"1351_CR101","doi-asserted-by":"crossref","unstructured":"Russo SC, Salas-Lucia F, Bianco AC. Deiodinases and the metabolic code for thyroid hormone action. Endocrinol. 2021;162(8):1\u201313.","DOI":"10.1210\/endocr\/bqab059"},{"key":"1351_CR102","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4274\/jcrpe.galenos.2024.2023-12-7","volume":"16","author":"B Sahoo","year":"2024","unstructured":"Sahoo B, Dabas A, Goswami B, Agarwal A, Kurian S. Non-thyroidal illness in children with congestive heart failure. J Clin Res Pediatr Endocrinol. 2024;16:192\u20139.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1351_CR103","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2213-8587(22)00004-3","volume":"10","author":"D Salvatore","year":"2022","unstructured":"Salvatore D, Porcelli T, Ettleson MD, Bianco AC. The relevance of T(3) in the management of hypothyroidism. Lancet Diabetes Endocrinol. 2022;10:366\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1351_CR104","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00001573-199605000-00002","volume":"11","author":"K Schwartz","year":"1996","unstructured":"Schwartz K, Mercadier JJ. Molecular and cellular biology of heart failure. Curr Opin Cardiol. 1996;11:227\u201336.","journal-title":"Curr Opin Cardiol"},{"key":"1351_CR105","doi-asserted-by":"publisher","first-page":"e7895","DOI":"10.1136\/bmj.e7895","volume":"345","author":"C Selmer","year":"2012","unstructured":"Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895.","journal-title":"BMJ"},{"key":"1351_CR106","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.amjcard.2012.02.068","volume":"110","author":"S Selvaraj","year":"2012","unstructured":"Selvaraj S, Klein I, Danzi S, Akhter N, Bonow RO, Shah SJ. Association of serum Triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction. Am J Cardiol. 2012;110:234\u20139.","journal-title":"Am J Cardiol"},{"key":"1351_CR107","doi-asserted-by":"publisher","first-page":"e4400","DOI":"10.1210\/clinem\/dgab478","volume":"106","author":"MKM Shakir","year":"2021","unstructured":"Shakir MKM, Brooks DI, McAninch EA, et al. Comparative effectiveness of levothyroxine, desiccated thyroid extract, and Levothyroxine\u2009+\u2009Liothyronine in hypothyroidism. J Clin Endocrinol Metab. 2021;106:e4400\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR108","doi-asserted-by":"crossref","unstructured":"Simonides W, Tijsma A, Boelen A et al. Divergent thyroid hormone levels in plasma and left ventricle of the heart in compensated and decompensated cardiac hypertrophy induced by chronic adrenergic stimulation in mice. Metabolites. 2023;13(2):308.","DOI":"10.3390\/metabo13020308"},{"key":"1351_CR109","doi-asserted-by":"publisher","first-page":"e0296413","DOI":"10.1371\/journal.pone.0296413","volume":"19","author":"H Singh","year":"2024","unstructured":"Singh H, Shahid MZ, Harrison SL, Lane DA, Lip GYH, Logantha S. Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis. PLoS ONE. 2024;19:e0296413.","journal-title":"PLoS ONE"},{"key":"1351_CR110","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3803\/EnM.2020.728","volume":"35","author":"SY Sohn","year":"2020","unstructured":"Sohn SY, Lee E, Lee MK, Lee JH. The association of overt and subclinical hyperthyroidism with the risk of cardiovascular events and cardiovascular mortality: Meta-Analysis and systematic review of cohort studies. Endocrinol Metab (Seoul). 2020;35:786\u2013800.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1351_CR111","first-page":"e147","volume":"2","author":"K Taira","year":"2010","unstructured":"Taira K, Fujino A, Watanabe T, Ogyu A, Ashikawa K, Shimizu W. Brugada-type electrocardiogram in a patient with hypothyroidism. J Cardiol Cases. 2010;2:e147\u201350.","journal-title":"J Cardiol Cases"},{"key":"1351_CR112","doi-asserted-by":"publisher","first-page":"17731","DOI":"10.1038\/s41598-019-53705-1","volume":"9","author":"L Tan","year":"2019","unstructured":"Tan L, Bogush N, Naib H, et al. Redox activation of JNK2alpha2 mediates thyroid hormone-stimulated proliferation of neonatal murine cardiomyocytes. Sci Rep. 2019;9:17731.","journal-title":"Sci Rep"},{"key":"1351_CR113","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/CIRCULATIONAHA.105.572883","volume":"112","author":"YD Tang","year":"2005","unstructured":"Tang YD, Kuzman JA, Said S, Anderson BE, Wang X, Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 2005;112:3122\u201330.","journal-title":"Circulation"},{"key":"1351_CR114","doi-asserted-by":"publisher","first-page":"363","DOI":"10.14423\/SMJ.0000000000000823","volume":"111","author":"A Tariq","year":"2018","unstructured":"Tariq A, Wert Y, Cheriyath P, Joshi R. Effects of Long-Term combination LT4 and LT3 therapy for improving hypothyroidism and overall quality of life. South Med J. 2018;111:363\u20139.","journal-title":"South Med J"},{"key":"1351_CR115","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(24)01614-3","volume":"404","author":"PN Taylor","year":"2024","unstructured":"Taylor PN, Medici MM, Hubalewska-Dydejczyk A, Boelaert K. Hypothyroidism Lancet. 2024;404:1347\u201364.","journal-title":"Hypothyroidism Lancet"},{"key":"1351_CR116","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2021.0609","volume":"32","author":"M Tharmapoopathy","year":"2022","unstructured":"Tharmapoopathy M, Thavarajah A, Kenny RPW, et al. Efficacy and safety of Triiodothyronine treatment in cardiac surgery or cardiovascular diseases: A systematic review and Meta-Analysis of randomized controlled trials. Thyroid. 2022;32:879\u201396.","journal-title":"Thyroid"},{"key":"1351_CR117","doi-asserted-by":"crossref","unstructured":"Theisen B, Holtz A, Rajagopalan V. Noncoding RNAs and human induced pluripotent stem Cell-Derived cardiomyocytes in cardiac arrhythmic Brugada syndrome. Cells. 2023;12(19):2398.","DOI":"10.3390\/cells12192398"},{"key":"1351_CR118","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/thy.2011.0183","volume":"22","author":"T Traub-Weidinger","year":"2012","unstructured":"Traub-Weidinger T, Graf S, Beheshti M, et al. Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine. Thyroid. 2012;22:245\u201351.","journal-title":"Thyroid"},{"key":"1351_CR119","doi-asserted-by":"publisher","first-page":"20319","DOI":"10.1038\/s41598-023-47391-3","volume":"13","author":"I Turic","year":"2023","unstructured":"Turic I, Velat I, Busic Z, Culic V. Circulating thyroid hormones and clinical parameters of heart failure in men. Sci Rep. 2023;13:20319.","journal-title":"Sci Rep"},{"key":"1351_CR120","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41598-021-04659-w","volume":"12","author":"A Ulivieri","year":"2022","unstructured":"Ulivieri A, Lavra L, Magi F, et al. Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in HiPSC cardiomyocytes. Sci Rep. 2022;12:568.","journal-title":"Sci Rep"},{"key":"1351_CR121","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the whickham survey. Clin Endocrinol (Oxf). 1995;43:55\u201368.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1351_CR122","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1210\/jc.2003-030249","volume":"88","author":"JP Walsh","year":"2003","unstructured":"Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine\/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;88:4543\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR123","doi-asserted-by":"publisher","first-page":"101473","DOI":"10.1016\/j.xcrm.2024.101473","volume":"5","author":"W Wang","year":"2024","unstructured":"Wang W, Zhang X, Gao J, et al. Effects of Levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: an open-label randomized trial. Cell Rep Med. 2024;5:101473.","journal-title":"Cell Rep Med"},{"key":"1351_CR124","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1210\/clinem\/dgac417","volume":"107","author":"X Wang","year":"2022","unstructured":"Wang X, Wang H, Li Q, et al. Effect of Levothyroxine supplementation on the cardiac morphology and function in patients with subclinical hypothyroidism: A systematic review and Meta-analysis. J Clin Endocrinol Metab. 2022;107:2674\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1351_CR125","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fphys.2020.00729","volume":"11","author":"K Wang","year":"2020","unstructured":"Wang K, Ojamaa K, Samuels A, et al. BNP as a new biomarker of cardiac thyroid hormone function. Front Physiol. 2020;11:729.","journal-title":"Front Physiol"},{"key":"1351_CR126","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1210\/en.2012-2087","volume":"154","author":"NY Weltman","year":"2013","unstructured":"Weltman NY, Ojamaa K, Savinova OV, et al. Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats. Endocrinology. 2013;154:2542\u201352.","journal-title":"Endocrinology"},{"key":"1351_CR127","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2119\/molmed.2013.00040","volume":"20","author":"NY Weltman","year":"2014","unstructured":"Weltman NY, Ojamaa K, Schlenker EH, et al. Low-dose T(3) replacement restores depressed cardiac T(3) levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus. Mol Med. 2014;20:302\u201312.","journal-title":"Mol Med"},{"key":"1351_CR128","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yjmcc.2006.09.017","volume":"42","author":"Y Wu","year":"2007","unstructured":"Wu Y, Peng J, Campbell KB, Labeit S, Granzier H. Hypothyroidism leads to increased collagen-based stiffness and re-expression of large cardiac Titin isoforms with high compliance. J Mol Cell Cardiol. 2007;42:186\u201395.","journal-title":"J Mol Cell Cardiol"},{"key":"1351_CR129","doi-asserted-by":"publisher","first-page":"bvac172","DOI":"10.1210\/jendso\/bvac172","volume":"7","author":"KL Wyne","year":"2022","unstructured":"Wyne KL, Nair L, Schneiderman CP, et al. Hypothyroidism prevalence in the united states: A retrospective study combining National health and nutrition examination survey and claims data, 2009\u20132019. J Endocr Soc. 2022;7:bvac172.","journal-title":"J Endocr Soc"},{"key":"1351_CR130","doi-asserted-by":"publisher","first-page":"606931","DOI":"10.3389\/fphys.2021.606931","volume":"12","author":"H Yamakawa","year":"2021","unstructured":"Yamakawa H, Kato TS, Noh JY, et al. Thyroid hormone plays an important role in cardiac function: from bench to bedside. Front Physiol. 2021;12:606931.","journal-title":"Front Physiol"},{"key":"1351_CR131","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.yjmcc.2014.04.005","volume":"72","author":"X Yang","year":"2014","unstructured":"Yang X, Rodriguez M, Pabon L, et al. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol. 2014;72:296\u2013304.","journal-title":"J Mol Cell Cardiol"},{"key":"1351_CR132","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijcard.2003.05.015","volume":"95","author":"M Yazici","year":"2004","unstructured":"Yazici M, Gorgulu S, Sertbas Y, et al. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. Int J Cardiol. 2004;95:135\u201343.","journal-title":"Int J Cardiol"},{"key":"1351_CR133","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1111\/j.1540-8159.2010.02960.x","volume":"35","author":"YH Zhao","year":"2012","unstructured":"Zhao YH, Zhang JY, Xu Y, Zhang XY. Hypothyroid patient with Brugada electrocardiographic waveforms: case report. Pacing Clin Electrophysiol. 2012;35:e222\u20135.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1351_CR134","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/clc.24057","volume":"46","author":"P Zhou","year":"2023","unstructured":"Zhou P, Huang L, Zhai M, et al. Prognostic role and relationship of thyroid dysfunction and lipid profile in hospitalized heart failure patients. Clin Cardiol. 2023;46:757\u201367.","journal-title":"Clin Cardiol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01351-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:03:05Z","timestamp":1772625785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-025-01351-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01351-x","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human (IRB) and animal (IACUC) protocol approvals are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors read and approved the final manuscript before submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"V.R. is an editor in the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}